Featured Analysis
Our latest deep-dive into a business.
In Portfolio
Stock is / was in Model Portfolio
Research Report21 Nov, 2025
Windlas Biotech - The Pill Maker
INSIGHTS
New plant, will produce oral solids and is soon to be operational.
Profit growth of ~17% when compared to the industry median of 12.4%
Is under government investigation for a recent cough syrup-related issue.
Yusuf Abdullah - PhD
10 min read
